Assistant Professor, Pediatrics, Children's Hospital, Harvard Medical School
Pediatric Hematology & Oncology
Dr. Rani E. George, MD
|
|
Give Review
Rani E. George works in the field of Pediatric Hematology & Oncology. Dr. Rani E. George is a published doctor and has 25 publications published. The lastest was: 'TERT rearrangements are frequent in neuroblastoma and identify aggressive tumors.'
Publications
- Seek and Ye Shall Find: Subclonal Anaplastic Lymphoma Kinase Mutations.
- TERT rearrangements are frequent in neuroblastoma and identify aggressive tumors.
- Targeting Transcriptional Addictions in Small Cell Lung Cancer with a Covalent CDK7 Inhibitor.
- CDK7 Inhibition Suppresses Super-Enhancer-Linked Oncogenic Transcription in MYCN-Driven Cancer.
- Mutations that disrupt PHOXB interaction with the neuronal calcium sensor HPCAL1 impede cellular differentiation in neuroblastoma.
- Activated ALK Collaborates with MYCN in Neuroblastoma Pathogenesis.
- Tumor histology during induction therapy in patients with high-risk neuroblastoma.
- Emerging importance of ALK in neuroblastoma.
- Discovery of 3,5-Diamino-1,2,4-triazole Ureas as Potent Anaplastic Lymphoma Kinase Inhibitors.
- Phase I study of decitabine with doxorubicin and cyclophosphamide in children with neuroblastoma and other solid tumors: a Children's Oncology Group study.
- Comparison of primary neuroblastoma tumors and derivative early-passage cell lines using genome-wide single nucleotide polymorphism array analysis.
- The kinesin KIF1Bbeta acts downstream from EglN3 to induce apoptosis and is a potential 1p36 tumor suppressor.
- Neuroblastoma cells isolated from bone marrow metastases contain a naturally enriched tumor-initiating cell.
- Genome-wide analysis of neuroblastomas using high-density single nucleotide polymorphism arrays.
- Does MYCN amplification manifested as homogeneously staining regions at diagnosis predict a worse outcome in children with neuroblastoma? A Children's Oncology Group s...
- High-risk neuroblastoma treated with tandem autologous peripheral-blood stem cell-supported transplantation: long-term survival update.
- Zebrafish foxd3 is selectively required for neural crest specification, migration and survival.
- Hyperdiploidy plus nonamplified MYCN confers a favorable prognosis in children 12 to 18 months old with disseminated neuroblastoma: a Pediatric Oncology Group study.
- Association between congenital cardiovascular malformations and neuroblastoma.
- Development of a real-time polymerase chain reaction assay for prediction of the uptake of meta-[(131)I]iodobenzylguanidine by neuroblastoma tumors.
- Anaplastic lymphoma kinase: role in Cancer pathogenesis and small-molecule inhibitor development for therapy.
- Activating mutations in ALK provide a therapeutic target in neuroblastoma.
- Pharmacotherapy of neuroblastoma.
- Expression of the neuron-specific protein CHD5 is an independent marker of outcome in neuroblastoma.
Schools
Am Dogliotti College Of Medicine University Of Liberia
Children39s Hospital
Children39s Hospital Boston
Conditions Treated
- Brain and Nervous System Cancer (incl. Gliomas, Astrocytoma, Schwannoma, Medulloblastoma, Chordoma)
- Neutropenia
- Soft Tissue Sarcoma
Doctors Specialties
- Pediatric Hematology
- Oncology
Accepted Insurances
Education
-
Boston Children's Hospital
Hospital
-
Boston Children's Hospital -
Brigham and Women's Hospital -
Dana-Farber Cancer Institute
Helpful Reviews
Similar Doctors
|
|
Dr. Cameron C. Trenor III, MD
 This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Alan B. Cantor, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Howard J. Weinstein, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Amy E. Sobota, MD
This Doctor is OpenDoctor Recommended.
|